# Optimizing Sysmex Technology as an Innovative Tool to Differentiate Between Malaria (PALUdism) and BACterial Infections in a Malaria Endemic Region

> **NCT02669823** · — · COMPLETED · sponsor: **Sysmex Europe GmbH** · enrollment: 930 (actual)

## Conditions studied

- Tropical Infectious Diseases

## Interventions

- **OTHER:** None, treatment as actual best practice

## Key facts

- **NCT ID:** NCT02669823
- **Lead sponsor:** Sysmex Europe GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-01
- **Primary completion:** 2017-06-30
- **Final completion:** 2017-06-30
- **Target enrollment:** 930 (ACTUAL)
- **Last updated:** 2017-07-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02669823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02669823, "Optimizing Sysmex Technology as an Innovative Tool to Differentiate Between Malaria (PALUdism) and BACterial Infections in a Malaria Endemic Region". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02669823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*